Biography:
Dalinda Eusébio completed her BSc in Biotechnology in 2016 and her MSc in Biomedical Sciences in 2018 at the University of Beira Interior, Portugal. Currently, she is pursuing her Ph.D. Degree in Biomedicine at the Health Sciences Research Centre of the University of Beira Interior (CICS-UBI) in collaboration with The University of Texas at Austin, supported by a Ph.D. fellowship from the Portuguese Foundation for Science and Technology (FCT). Her research focuses on pharmaceutical nanobiotechnology, specifically on the production, purification, and targeted delivery of the innovative minicircle DNA vector for gene therapy and DNA vaccine applications.
Title : Targeted delivery of a minicircle DNA vaccine against COVID-19 to antigen-presenting cells using mannosylated polyethylenimine-cholesterol-based nanoparticles